Sabal Trust CO Amgen Inc Transaction History

Sabal Trust CO

$1.68 Billion
Q2 2024

A detailed history of Sabal Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Sabal Trust CO holds 85,167 shares of AMGN stock, worth $27.5 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

85,167

Previous 86,451 1.49%

Holding current value

$27.5 Million

Previous $24.6 Million 8.26%

% of portfolio

1.59%

Previous 1.43%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $337,371 - $409,994	-1,284 Reduced 1.49%	85,167 $26.6 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $13,443 - $16,228	-50 Reduced 0.06%	86,451 $24.6 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $579,416 - $653,650	-2,266 Reduced 2.55%	86,501 $24.9 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $96,206 - $119,442	-440 Reduced 0.49%	88,767 $23.9 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $230,340 - $272,372	1,075 Added 1.22%	89,207 $19.8 Million
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $655,016 - $798,355	2,901 Added 3.4%	88,132 $21.3 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $3,893 - $4,947	17 Added 0.02%	85,231 $22.4 Million
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $475,630 - $536,424	2,119 Added 2.55%	85,214 $19.2 Million
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $18.9 Million - $21.1 Million	82,131 Added 8519.81%	83,095 $20.2 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $211,376 - $233,837	964 New	964 $233,000
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $180,854 - $211,892	-852 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $189,067 - $220,327	852 New	852 $212,000
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $176,782 - $210,516	-817 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $191,709 - $213,196	817 New	817 $208,000
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $24.3 Million - $28.4 Million	-145,535 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$180.87 - $203.88 $158,984 - $179,210	879 Added 0.61%	145,535 $27.6 Million
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $1.27 Million - $1.48 Million	-7,098 Reduced 4.68%	144,656 $28.2 Million
Q3 2018 Oct 16, 2018	SELL	$185.29 - $208.89 $47,990 - $54,102	-259 Reduced 0.17%	151,754 $31.5 Million
Q2 2018 Jul 16, 2018	BUY	$166.05 - $186.51 $1.05 Million - $1.17 Million	6,295 Added 4.32%	152,013 $28.1 Million
Q1 2018 Apr 16, 2018	BUY	$169.43 - $198.0 $773,956 - $904,464	4,568 Added 3.24%	145,718 $24.8 Million
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $243,732 - $272,323	1,444 Added 1.03%	141,150 $24.5 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $23.4 Million - $26.7 Million	139,706	139,706 $26 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.

Account